LIQUIDIA CORPORATION -

Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8:00am E.T.

31 Aug 2022 18:46:18 By Nasdaq GlobeNewswire

Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

22 Aug 2022 06:00:35 By Nasdaq GlobeNewswire

Liquidia Reports Second Quarter 2022 Financial Results and Provides Corporate Update

11 Aug 2022 05:45:29 By Nasdaq GlobeNewswire

Liquidia to Report Second Quarter 2022 Financial Results on August 11, 2022

04 Aug 2022 07:18:50 By Nasdaq GlobeNewswire

Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

25 Jul 2022 07:51:48 By Nasdaq GlobeNewswire

Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

21 Jul 2022 15:30:00 By Nasdaq GlobeNewswire

Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent

19 Jul 2022 15:30:09 By Nasdaq GlobeNewswire

Liquidia Corporation Added to Russell 2000® and 3000® Indexes

27 Jun 2022 05:26:08 By Nasdaq GlobeNewswire

Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

24 Jun 2022 15:15:52 By Nasdaq GlobeNewswire

Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

24 Jun 2022 08:35:45 By Nasdaq GlobeNewswire

Liquidia Appoints Rajeev Saggar, M.D., as Chief Medical Officer

20 Jun 2022 06:00:11 By Nasdaq GlobeNewswire

Liquidia Announces Presentation at the 2022 Pulmonary Hypertension Association (PHA) International Conference

09 Jun 2022 15:30:53 By Nasdaq GlobeNewswire

Update to Liquidia’s Participation in the Jefferies Healthcare Conference

07 Jun 2022 15:30:04 By Nasdaq GlobeNewswire

Liquidia to Participate in the Jefferies Healthcare Conference

02 Jun 2022 08:04:17 By Nasdaq GlobeNewswire

Liquidia Announces Presentations at the 2022 American Thoracic Society (ATS) International Conference

16 May 2022 06:30:53 By Nasdaq GlobeNewswire

Liquidia Reports First Quarter 2022 Financial Results and Provides Corporate Update

12 May 2022 06:00:27 By Nasdaq GlobeNewswire

Liquidia to Report First Quarter 2022 Financial Results on May 12, 2022

05 May 2022 07:00:51 By Nasdaq GlobeNewswire

Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

25 Apr 2022 07:45:41 By Nasdaq GlobeNewswire

Liquidia Announces Oral Presentation at the 42nd Annual Meeting of International Society for Heart and Lung Transplant (ISHLT)

20 Apr 2022 09:01:09 By Nasdaq GlobeNewswire

Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment Option

18 Apr 2022 15:05:20 By Nasdaq GlobeNewswire